Alberta's Strategic Clinical Networks: A roadmap for the future

Healthcare Management Forum
Braden J MannsTracy Wasylak

Abstract

Clinical networks are groups of clinicians, patients, operational leaders, and other stakeholders who work together to solve health challenges, translate evidence into practice, and improve health outcomes and clinical care. Networks enable health, community, and academic partners to align their efforts, address priority issues, and advance quality improvements, health innovation, and transformational change on a local and system-wide scale. Clinical networks have existed in some countries for nearly 20 years. Alberta first implemented clinical networks in 2012 in specific areas of health. There are now 16 Strategic Clinical Networks (SCNs) in Alberta, embedded within a province-wide health system. The SCNs have developed an action plan that builds on their experience and identifies common areas of focus. This article describes the SCNs, their impact to date, and the objectives, areas of focus, and processes Alberta's SCNs will use to improve health outcomes and health system performance over the next 5 years.

References

Apr 24, 2004·Cost Effectiveness and Resource Allocation : C/E·Craig Mitton, Cam Donaldson
Jul 12, 2007·The International Journal of Health Planning and Management·Bengt Ahgren, Runo Axelsson
Feb 2, 2010·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Krishna K VaradhanDileep N Lobo
Jun 12, 2013·The British Journal of Surgery·D RoulinN Demartines
Nov 7, 2015·BMC Health Services Research·Elizabeth McInnesEmily Klineberg
Dec 6, 2018·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Noreen KamalJennifer Bestard
Jan 18, 2019·Public Health Research & Practice·Mary M HainesSally Redman
Feb 13, 2019·Critical Pathways in Cardiology·Noreen KamalUNKNOWN QuICR Alberta Stroke Program

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

AHS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
David J Ballard
Chinese Medical Journal
James NguyenTheodore A Bass
Diseases of the Colon and Rectum
Ken K H LeeElizabeth C Wick
© 2021 Meta ULC. All rights reserved